Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance

被引:30
作者
Metcalfe, John Z. [1 ]
Streicher, Elizabeth [2 ,3 ]
Theron, Grant [2 ,3 ]
Colman, Rebecca E. [4 ]
Allender, Christopher [5 ]
Lemmer, Darrin [5 ]
Warren, Rob [2 ,3 ]
Engelthaler, David M. [5 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,Rm 5K1, San Francisco, CA 94110 USA
[2] Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa
[3] Stellenbosch Univ, Fac Med & Hlth Sci, SAMRC Ctr TB Res, Div Mol Biol & Human Genet, Tygerberg, South Africa
[4] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA
[5] Translat Genom Res Inst, Flagstaff, AZ USA
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
next-generation sequencing; Sanger sequencing; drug-resistant tuberculosis; diagnostics; DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; HETERO-RESISTANCE; GENOMIC ANALYSIS; SOUTH-AFRICA; HETERORESISTANCE; SUSCEPTIBILITY; MUTATIONS; DIAGNOSIS;
D O I
10.1164/rccm.201703-0556OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays. Objectives: To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations. Methods: We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error, to analyze primary cultured isolates phenotypically resistant to rifampin, fluoroquinolones, or aminoglycosides, but for which Sanger sequencing found no resistance-associated variants (RAVs) within respective resistance-determining regions (study group). Isolates also underwent single-colony selection on antibiotic-containing agar, blinded to sequencing results. As a positive control, isolates with multiple colocalizing chromatogram peaks were also analyzed (control group). Measurements and Main Results: Among 61 primary culture isolates (25 study group and 36 control group), SMOR described 66 (49%) and 45 (33%) of 135 total heteroresistant RAVs at frequencies less than 5% and less than 1% of the total mycobacterial population, respectively. In the study group, SMOR detected minor resistant variant subpopulations in 80% (n = 20/25) of isolates with no Sanger-identified RAVs (median subpopulation size, 1.0%; interquartile range, 0.2-3.9%). Single-colony selection on drug-containing media corroborated SMOR results for 90% (n = 18/20) of RAV-containing specimens, and the absence of RAVs in 60% (n = 3/5) of isolates. Overall, Sanger sequencing was concordant with SMOR for 77% (n = 53/69) of macroheteroresistant (5-95% total population), but only 5% of microheteroresistant (< 5%) subpopulations (n = 3/66) across both groups. Conclusions: Cryptic minor variant mycobacterial subpopulations exist below the resolving capability of current drug susceptibility testing methodologies, and may explain an important proportion of false-negative resistance determinations.
引用
收藏
页码:1191 / 1201
页数:11
相关论文
共 50 条
  • [31] Universal Lineage-Independent Markers of Multidrug Resistance in Mycobacterium tuberculosis
    Hlanze, Hleliwe
    Mutshembele, Awelani
    Reva, Oleg N.
    MICROORGANISMS, 2024, 12 (07)
  • [32] pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis
    Sheen, Patricia
    Lozano, Katherine
    Gilman, Robert H.
    Valencia, Hugo J.
    Loli, Sebastian
    Fuentes, Patricia
    Grandjean, Louis
    Zimic, Mirko
    TUBERCULOSIS, 2013, 93 (05) : 515 - 522
  • [33] Rifoligotyping assay: an alternative method for rapid detection of rifampicin resistance in Mycobacterium tuberculosis isolates from Morocco
    Chaoui, Imane
    Atalhi, Naima
    Sabouni, Radia
    Akrim, Mohammed
    Abid, Mohammed
    Amzazi, Saaid
    ElMzibri, Mohammed
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2014, 28 (06) : 1095 - 1102
  • [34] Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China
    Liu, W.
    Chen, J.
    Shen, Y.
    Jin, J.
    Wu, J.
    Sun, F.
    Wu, Y.
    Xie, L.
    Zhang, Y.
    Zhang, W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (09) : 1016.e1 - 1016.e5
  • [35] Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
    Shen, Gwan-Han
    Tsao, Thomas Chang-Yao
    Kao, Shang-Jyh
    Lee, Jen-Jyh
    Chen, Yen-Hsu
    Hsieh, Wei-Chung
    Hsu, Gwo-Jong
    Hsu, Yen-Tao
    Huang, Ching-Tai
    Lau, Yeu-Jun
    Tsao, Shih-Ming
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (03) : 201 - 205
  • [36] Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
    Radhakrishnan, Ramalingam
    Prabuseenivasan, S.
    Hannah, S.
    Vaishanavee, V.
    Senthildevi, V
    Kannadhasan, T.
    Suchithra, R.
    Rajendran, Priya
    Chinnaiyan, Ponnuraja
    Jayabal, Lavanya
    Frederick, Asha
    Shanmugam, Sivakumar
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2023, 12 (03) : 299 - 304
  • [37] Evaluation of Two Molecular Assays for Rapid Detection of Mycobacterium tuberculosis Resistance to Fluoroquinolones in High-Tuberculosis and -Multidrug-Resistance Settings
    Kontsevaya, I.
    Mironova, S.
    Nikolayevskyy, V.
    Balabanova, Y.
    Mitchell, S.
    Drobniewski, F.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (08) : 2832 - 2837
  • [38] Clinical Outcomes Among Persons With Pulmonary Tuberculosis Caused by Mycobacterium tuberculosis Isolates With Phenotypic Heterogeneity in Results of Drug-Susceptibility Tests
    Zetola, Nicola M.
    Modongo, Chawangwa
    Moonan, Patrick K.
    Ncube, Ronald
    Matlhagela, Keikantse
    Sepako, Enoch
    Collman, Ronald G.
    Bisson, Gregory P.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (11) : 1754 - 1763
  • [39] The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in Mycobacterium tuberculosis isolates from untreated pulmonary Tuberculosis cases in urban Blantyre, Malawi
    Kumwenda, Geoffrey P.
    Chipungu, Geoffrey
    Sloan, Derek J.
    Kaimila, Yankho
    Chiumya, Kondwani
    Pangani, Harry
    MALAWI MEDICAL JOURNAL, 2018, 30 (01) : 1 - 5
  • [40] Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review
    Kontsevaya, Irina
    Werngren, Jim
    Holicka, Yen
    Klaos, Kadri
    Tran, Anh
    Nikolayevskyy, Vladyslav
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (03) : 415 - 426